122 related articles for article (PubMed ID: 37661831)
1. The recalibration and redevelopment of a model to calculate patients' probability of completing a colonoscopy following an abnormal fecal test.
Petrik AF; Johnson ES; Slaughter M; Leo MC; Thompson J; Mummadi RR; Jimenez R; Hussain SA; Coronado G
J Med Screen; 2024 Mar; 31(1):28-34. PubMed ID: 37661831
[TBL] [Abstract][Full Text] [Related]
2. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics.
Petrik AF; Keast E; Johnson ES; Smith DH; Coronado GD
BMC Health Serv Res; 2020 Nov; 20(1):1028. PubMed ID: 33172444
[TBL] [Abstract][Full Text] [Related]
3. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center.
Escaron AL; Garcia J; Petrik AF; Ruiz E; Nyongesa DB; Thompson JH; Coronado GD
J Prim Care Community Health; 2022; 13():21501319221138423. PubMed ID: 36448466
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic colonoscopy completion after abnormal fecal immunochemical testing and quality of tests used at 8 Federally Qualified Health Centers in Southern California: Opportunities for improving screening outcomes.
Bharti B; May FFP; Nodora J; Martínez ME; Moyano K; Davis SL; Ramers CB; Garcia-Bigley F; O'Connell S; Ronan K; Barajas M; Gordon S; Diaz G; Ceja E; Powers M; Arredondo EM; Gupta S
Cancer; 2019 Dec; 125(23):4203-4209. PubMed ID: 31479529
[TBL] [Abstract][Full Text] [Related]
5. Equitable Implementation of Mailed Stool Test-Based Colorectal Cancer Screening and Patient Navigation in a Safety Net Health System.
Scott RE; Chang P; Kluz N; Baykal-Caglar E; Agrawal D; Pignone M
J Gen Intern Med; 2023 May; 38(7):1631-1637. PubMed ID: 36456842
[TBL] [Abstract][Full Text] [Related]
6. Abnormal Colorectal Cancer Test Follow-Up: A Quality Improvement Initiative at a Federally Qualified Health Center.
Shareef F; Bharti B; Garcia-Bigley F; Hernandez M; Nodora J; Liu J; Ramers C; Nery JD; Marquez J; Moyano K; Rojas S; Arredondo E; Gupta S
J Prim Care Community Health; 2024; 15():21501319241242571. PubMed ID: 38554066
[TBL] [Abstract][Full Text] [Related]
7. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
[TBL] [Abstract][Full Text] [Related]
8. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
[TBL] [Abstract][Full Text] [Related]
9. Barriers and Facilitators of Colorectal Cancer Screening in a Federally Qualified Health Center (FQHC).
Ylitalo KR; Camp BG; Umstattd Meyer MR; Barron LA; Benavidez G; Hess B; Laschober R; Griggs JO
J Am Board Fam Med; 2019; 32(2):180-190. PubMed ID: 30850454
[TBL] [Abstract][Full Text] [Related]
10. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
11. Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy.
Cusumano VT; Corona E; Partida D; Yang L; Yu C; May FP
BMC Gastroenterol; 2020 Apr; 20(1):115. PubMed ID: 32306919
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015-2016.
Almansoori A; Alzaabi M; Alketbi L
BMC Cancer; 2021 Aug; 21(1):897. PubMed ID: 34362343
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
[TBL] [Abstract][Full Text] [Related]
14. Patients' perceptions of colorectal cancer screening tests and preparatory education in federally qualified health centers.
Gwede CK; Koskan AM; Quinn GP; Davis SN; Ealey J; Abdulla R; Vadaparampil ST; Elliott G; Lopez D; Shibata D; Roetzheim RG; Meade CD;
J Cancer Educ; 2015 Jun; 30(2):294-300. PubMed ID: 25249181
[TBL] [Abstract][Full Text] [Related]
15. Patient-Reported Barriers to Completing a Diagnostic Colonoscopy Following Abnormal Fecal Immunochemical Test Among Uninsured Patients.
Jetelina KK; Yudkin JS; Miller S; Berry E; Lieberman A; Gupta S; Balasubramanian BA
J Gen Intern Med; 2019 Sep; 34(9):1730-1736. PubMed ID: 31228053
[TBL] [Abstract][Full Text] [Related]
16. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health system.
Singal AG; Gupta S; Tiro JA; Skinner CS; McCallister K; Sanders JM; Bishop WP; Agrawal D; Mayorga CA; Ahn C; Loewen AC; Santini NO; Halm EA
Cancer; 2016 Feb; 122(3):456-63. PubMed ID: 26535565
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial.
Gupta S; Halm EA; Rockey DC; Hammons M; Koch M; Carter E; Valdez L; Tong L; Ahn C; Kashner M; Argenbright K; Tiro J; Geng Z; Pruitt S; Skinner CS
JAMA Intern Med; 2013 Oct; 173(18):1725-32. PubMed ID: 23921906
[TBL] [Abstract][Full Text] [Related]
18. Role of double-contrast barium enema in colorectal cancer screening based on fecal occult blood.
Ciatto S; Castiglione G
Tumori; 2002; 88(2):95-8. PubMed ID: 12088265
[TBL] [Abstract][Full Text] [Related]
19. Cost and Effectiveness of Reminders to Promote Colorectal Cancer Screening Uptake in Rural Federally Qualified Health Centers in West Virginia.
Conn ME; Kennedy-Rea S; Subramanian S; Baus A; Hoover S; Cunningham C; Tangka FKL
Health Promot Pract; 2020 Nov; 21(6):891-897. PubMed ID: 32990048
[TBL] [Abstract][Full Text] [Related]
20. Reasons for Lack of Diagnostic Colonoscopy After Positive Result on Fecal Immunochemical Test in a Safety-Net Health System.
Martin J; Halm EA; Tiro JA; Merchant Z; Balasubramanian BA; McCallister K; Sanders JM; Ahn C; Bishop WP; Singal AG
Am J Med; 2017 Jan; 130(1):93.e1-93.e7. PubMed ID: 27591183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
